Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. This study looked at the concordance between outcomes reported by acromegaly patients treated with long-acting somatostatin receptor ligands (SRLs) and those perceived by their medical provider. It found that while medical providers reported that their patients experienced acromegaly symptoms on a regular basis, there was poor agreement between patients and medical providers on the frequency, severity, and pattern of symptoms, as well as the other outcomes. The authors conclude that addressing discordance in patient- and medical provider-reported frequency and severity of symptoms and injection site reactions via better communication may improve care of acromegaly patients. To read the full publication or download its PDF, click here.
Geer EB, Sisco J, Adelman DT, et al. Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider. Pituitary. 2020;23(2):140-148. doi:10.1007/s11102-019-01013-2